Is Superdrug-Owner AS Watson Gearing up for a $30 Billion Dual IPO?

Why It Matters

A $30 bn dual IPO would provide AS Watson with substantial funding to accelerate global growth, while offering investors exposure to the fast‑growing health‑and‑beauty sector. The move also signals heightened appetite for cross‑border listings amid market volatility.

Key Takeaways

• AS Watson may target a $30 bn valuation in 2026 dual IPO
• Potential $2 bn proceeds could fund global expansion and brand acquisitions
• Listing could occur on both London Stock Exchange and Hong Kong Stock Exchange
• CK Hutchison has not confirmed any IPO plans, keeping investors cautious

Pulse Analysis

AS Watson, the conglomerate behind Superdrug and The Perfume Shop, is rumored to be eyeing a dual initial public offering that would span the London Stock Exchange and Hong Kong’s market. Dual listings have become a strategic tool for multinational firms seeking diversified investor bases and currency hedging, especially as Asian capital markets rebound after recent headwinds. By positioning itself in both financial hubs, AS Watson could tap deep liquidity pools while showcasing its commitment to global growth.

If the speculation proves true, the proposed US$30 billion valuation would place AS Watson among the largest health‑and‑beauty entities to go public, rivaling peers like L'Oréal and Estée Lauder. The anticipated US$2 billion raise would likely be earmarked for expanding its retail footprint across emerging markets, accelerating e‑commerce capabilities, and pursuing strategic acquisitions to broaden its product portfolio. For CK Hutchison, the parent company, an IPO could unlock value from a non‑core asset, providing capital for its broader conglomerate strategy while reducing debt exposure.

Investors are watching the development closely, as a successful dual IPO could set a precedent for other Asian‑owned consumer brands seeking Western capital. However, the lack of official confirmation introduces uncertainty, and market participants will weigh macro‑economic factors such as interest‑rate trends and geopolitical tensions. Should the offering launch in 2026, it will test the resilience of cross‑border equity markets and could reshape the competitive dynamics of the global beauty and wellness sector.